| Date | Title | Description |
| 05.10.2021 | Nyxoah announces CE-mark approval to treat Complete Concentr... | Utrecht, The Netherlands & Mont-Saint-Guibert, Belgium - Nyxoah SA (Euronext Brussels/Nasdaq: NY... |
| 04.10.2021 | Noema Pharma appoints Jeffrey Jonas as independent Chairman ... | Utrecht, The Netherlands & Basel, Switzerland - Noema Pharma, a Swiss-based clinical stage compa... |
| 29.09.2021 | Acacia Pharma announces Marketing Authorization Application ... | Utrecht, The Netherlands, Cambridge, UK & Indianapolis, US - Acacia Pharma (EURONEXT: ACPH), a c... |
| 24.09.2021 | Gilde Healthcare names Robert Stein as Partner in Germany | With more than 25 years of Private Equity investment experience in ‘Mittelstand’ companies in the DA... |
| 21.09.2021 | Amphista Therapeutics appoints new chairman, Joshua T. Brumm | Utrecht, The Netherlands & Glasgow, Scotland - Amphista Therapeutics, a leader in next generatio... |
| 15.09.2021 | Nyxoah announces U.S. FDA breakthrough device designation gr... | Utrecht (the Netherlands) & Cambridge (Massachusetts - US) - Nyxoah SA (Euronext Brussels/Nasdaq... |
| 08.09.2021 | AM-Pharma signs exclusive license agreement with Kyowa Kirin... | Utrecht, The Netherlands & Tokyo, Japan - AM-Pharma B.V., an emerging leader focused on developi... |
| 05.08.2021 | Noema Pharma initiates Phase 2a Allevia study of PDE10A inhi... | Basel – Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system (... |
| 14.07.2021 | Spire Health closes $38 million financing round led by Gilde... | San Francisco (California, US) & Cambridge (Massachusetts, US) – Spire Health, the leading provi... |
| 13.07.2021 | LAVA Therapeutics announces treatment of first patient in Ph... | Utrecht (the Netherlands) & Philadelphia (US) – Gilde Healthcare portfolio company LAVA Therapeu... |
| 07.07.2021 | Adcendo appoints Michael Pehl as Chief Executive Officer | Utrecht (the Netherlands) & Copenhagen (Denmark) – Gilde Healthcare portfolio company Adcendo, a... |
| 02.07.2021 | Gilde Healthcare portfolio company Nyxoah realizes successfu... | Utrecht (the Netherlands) & Mont-Saint-Guibert (Belgium) – Gilde Healthcare portfolio company Ny... |
| 01.07.2021 | Gilde Healthcare portfolio company CVRx realizes successful ... | Utrecht (the Netherlands) & Minneapolis (USA) – Gilde Healthcare portfolio company CVRx Inc., a ... |
| 07.06.2021 | Nyxoah BETTER SLEEP trial reaches its primary endpoints | Utrecht (the Netherlands) & Mont-Saint-Guibert (Belgium) – Nyxoah, a medical technology company ... |
| 02.06.2021 | Gilde Healthcare appoints Joep Muijrers to lead investments ... | Utrecht (the Netherlands) – Gilde Healthcare, a specialized healthcare investor with €1.4 billion un... |
| 25.05.2021 | Gilde Healthcare's Private Equity fund sells majority stake ... | Keensight Capital, one of the principal private equity managers dedicated to pan-European Growth Buy... |
| 06.05.2021 | Gilde Healthcare acquires majority stake in Danish drug deve... | Utrecht (the Netherlands) and Copenhagen (Denmark) – Gilde Healthcare, a specialized healthcare inve... |
| 29.04.2021 | Gilde Healthcare participates in €51M series A financing of ... | Utrecht (the Netherlands) and Copenhagen (Denmark) – ADCendo ApS (“Adcendo”), a Danish biopharmaceut... |
| 27.04.2021 | The Private Equity fund of Gilde Healthcare acquires German ... | Utrecht (the Netherlands) and Freienstau – The Private Equity fund of Gilde Healthcare, a specialist... |
| 26.04.2021 | Gilde Healthcare supports national roll out of dental chain ... | Utrecht and Eindhoven (the Netherlands) – Gilde Healthcare, a specialized healthcare investor with €... |
| 19.04.2021 | RAD-x adds Medizin Center Bonn to its fast growing diagnosti... | Utrecht (the Netherlands) and Mannheim (Germany) – RAD-x, the leading European diagnostic imaging pr... |
| 16.04.2021 | LUMICKS raises $93 million in Series D financing | Amsterdam, the Netherlands – LUMICKS, a leading, next generation life science tools company that dev... |
| 25.03.2021 | Gilde Healthcare announces successful pricing of Nasdaq IPO ... | Utrecht, the Netherlands – Gilde Healthcare, a specialized healthcare investor with $1.8 billion und... |
| 17.03.2021 | Amphista Therapeutics raises $53M in Series B round co-led b... | Glasgow, UK - Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) ... |
| 01.03.2021 | Axonics® expands into stress urinary incontinence with the a... | IRVINE, California US – Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology c... |
| 01.03.2021 | Ace Pharmaceuticals strengthens shareholders base | Zeewolde, the Netherlands – Ace Pharmaceuticals (Ace), a specialized pharmaceutical company in medic... |
| 22.02.2021 | LAVA Therapeutics Appoints Dr. Kapil Dhingra as Chairman of ... | Utrecht, The Netherlands and Philadelphia, USA – LAVA Therapeutics B.V., an early clinical-stage bio... |
| 19.02.2021 | Acacia Pharma (EURONEXT: ACPH) raises EUR 27 million for US ... | Cambridge, UK and Indianapolis, US – Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmaceu... |
| 02.02.2021 | Nyxoah and Vanderbilt University enter exclusive licensing a... | Utrecht (The Netherlands) – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technol... |
| 28.01.2021 | Acacia Pharma launches BYFAVO™ in the United States for proc... | Cambridge (UK), Indianapolis (US) and Utrecht (the Netherlands) - Acacia Pharma (EURONEXT: ACPH), a ... |
| 26.01.2021 | Nyxoah announces full-body MRI compatibility for the Genio® ... | Utecht (The Netherlands) – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technolo... |
| 20.01.2021 | Acacia Pharma wins BEL Company of the Year for the second co... | This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regu... |
| 19.01.2021 | RAD-x adds Radiologisches Zentrum Lahnstein (RZL) to its gro... | Utrecht (the Netherlands) – RAD-x is welcoming Radiologisches Zentrum Lahnstein (“RZL”) in its group... |
| 08.01.2021 | AM-Pharma announces enrollment and financing of COVID-19 coh... | Utrecht (the Netherlands) - AM-Pharma B.V., an emerging leader focused on the treatment of kidney di... |
| 06.01.2021 | Gilde Healthcare leads $28 million financing in Volta Medica... | Marseille (France) - Utrecht (the Netherlands) – Volta Medical, a French-based HealthTech startup, p... |
| 01.12.2020 | Gilde Healthcare participates in €51M series A financing of ... | Basel (Switzerland) – Noema Pharma (‘Noema”) AG, a Swiss clinical-stage company targeting orphan neu... |
| 01.12.2020 | Vesper Medical Announces First Enrollment in the VIVID Trial | Malvern, PA — Vesper Medical, Inc., a developer of medical devices for deep venous disease, today an... |
| 19.11.2020 | MercachemSyncom changes name to Symeres |
Nijmegen (The Netherlands) – MercachemSyncom today announced that it will change its name and oper... |
| 16.11.2020 | Calypso Biotech announces successful dosing of first Phase 1... | Dose-escalation study to evaluate safety, biological and early clinical effect of CALY-002 in health... |
| 13.11.2020 | Inari Medical Announces Presentation of Positive 30-Day Foll... | IRVINE, Calif. — (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage... |
| 12.11.2020 | AM-PHARMA Announces Enrollment of the First Patient in REVIV... | Utrecht, The Netherlands – AM-Pharma B.V., an emerging leader focused on the treatment of kidney dis... |
| 09.11.2020 | Drug discovery CRO MercachemSyncom adds biology services thr... | Utrecht (the Netherlands) – Gilde Healthcare portfolio company MercachemSyncom, the leading mid-size... |
| 16.10.2020 | Eargo, Inc. announces pricing of Initial Public Offering | San Jose (CA, US) – Eargo, Inc. (“Eargo”), a medical device company dedicated to improving the quali... |
| 17.09.2020 | Lava Therapeutics announces $83 million series C financing t... | Utrecht (The Netherlands) and Philadelphia – Gilde Healthcare company Lava Therapeutics announced th... |
| 17.09.2020 | Nyxoah raises up to €85 million (US$100M) in successful init... | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INT... |
| 27.08.2020 | Nyxoah announces intention to launch an Initial Public Offer... | Mont-Saint-Guibert (Belgium) and Utrecht (The Netherlands) – Nyxoah S.A. (“Nyxoah” or the “Company”)... |
| 24.08.2020 | Acacia Pharma commercially launches BARHEMSYS® in the US for... | Cambridge (UK) and Indianapolis (US) – Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmac... |
| 14.08.2020 | Acacia Pharma raises €25M to launch BARHEMSYS® and BYFAVO™ i... | Cambridge (UK) and Indianapolis (US) – Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmac... |
| 11.08.2020 | Lumeon raises $30M to fuel growth in the US | Boston (Massachusetts, US) and Utrecht (The Netherlands) – Lumeon, the leader in care pathway orches... |
| 31.07.2020 | LUMICKS enters collaboration with Glycostem to enhance NK ce... | Utrecht (The Netherlands) and Amsterdam (The Netherlands) – LUMICKS has entered into a collaboration... |
| 30.07.2020 | Gilde Healthcare Partners co-leads $71 million financing rou... | Utrecht (The Netherlands) and Boston (Massachusetts, US) – Eargo Inc. (San Jose, CA), a medical devi... |
| 29.07.2020 | Gilde Healthcare leads $60 million growth financing round in... | Paris (France) and Utrecht (The Netherlands) – Withings, an early pioneer of connected health device... |
| 08.07.2020 | CVRx® raises $50 million in new equity financing | Utrecht (The Netherlands) and Boston (Massachusetts, US) – CVRx, Inc., a private medical device comp... |
| 03.07.2020 | Acacia Pharma announces US FDA approval of BYFAVO™ (remimazo... | CAMBRIDGE (UK), INDIANAPOLIS (US) – Acacia Pharma (EURONEXT: ACPH), a commercial stage biopharmaceut... |
| 03.07.2020 | CVRx® announces publication of BeAt-HF clinical study result... | MINNEAPOLIS (US) – CVRx, Inc., a private medical device company, announced today that its BeAT-HF ph... |
| 18.06.2020 | Gilde Healthcare leads $39 million in Series B financing in ... | SAN FRANCISCO, CA (US), UTRECHT (THE NETHERLANDS) – Big Health, the global leader in digital therape... |
| 27.05.2020 | Inari Medical closes upsized initial public offering | IRVINE, CALIFORNIA – Inari Medical Inc. today announced the closing of its initial public offering o... |
| 15.05.2020 | Lava Therapeutics announces collaboration with Johnson &... | Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – Dutch biopharmaceutical start-up Lava Th... |
| 11.05.2020 | Vapotherm raises $87 million via public offering | Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – Vapotherm, Inc. (NYSE: VAPO), a global m... |
| 11.05.2020 | Axonics Modulation Technologies raises $130 million via publ... | Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – Axonics Modulation Technologies, Inc. (N... |
| 31.03.2020 | Gilde Healthcare raises €416 million ($450 million) venture ... | Utrecht (the Netherlands), Cambridge, Massachusetts (USA) – Gilde Healthcare today announces the fir... |
| 24.03.2020 | Respiratory company Vapotherm provides business update in re... | New Hampshire (United States) – Vapotherm, Inc. (NYSE: VAPO), the Gilde Healthcare company focused o... |
| 03.03.2020 | Acacia Pharma announces year and results and outlook 2020 | Cambridge (United Kingdom) and Indianapolis (United States) – Acacia Pharma (EURONEXT: ACPH), a hosp... |
| 27.02.2020 | Acacia Pharma announces US FDA approval of BARHEMSYS® to tre... | Cambridge (United Kingdom) and Indianapolis (United States) – Gilde Healthcare company Acacia Pharma... |
| 20.02.2020 | Ablative Solutions Announces Publication of Data from the Pe... | SAN JOSE, Calif. — Ablative Solutions, Inc., a company pioneering new approaches for the treatment o... |
| 13.02.2020 | First patient dosed in pivotal phase 3 trial of SNF472 in ca... | First patient dosed in phase 3 trial of SNF472 for the treatment of calcific uremic arteriolopathy (... |
| 04.02.2020 | Axonics® receives reimbursement approval in Germany for its ... | Irvine, CA (United States) – Gilde Healthcare portfolio company Axonics Modulation Technologies, Inc... |
| 24.01.2020 | Acacia Pharma wins BEL Small Company of the Year Award 2019 | Cambridge (United Kingdom) and Indianapolis (United States) – Gilde Healthcare portfolio company Aca... |
| 10.01.2020 | Acacia Pharma signs strategic in-licensing and finance agree... | Cambridge (United Kingdom) and Indianapolis (United States) – Gilde Healthcare portfolio company Aca... |
| 09.01.2020 | MercachemSyncom acquires the European operations of Alcami | Utrecht (the Netherlands) – Gilde Healthcare portfolio company MercachemSyncom, the leading mid-size... |
| 09.01.2020 | Lava Therapeutics appoints immuno-oncology experts James All... | Utrecht (the Netherlands) and Philadelphia (United States) – Gilde Healthcare company Lava Therapeut... |
| 18.12.2019 | Gilde Healthcare exits occupational health provider BlijWerk... | Utrecht (the Netherlands) – Gilde Healthcare today announced it has sold its majority stake in occup... |
| 04.12.2019 | Lumeon partners with Medtronic on value-based care | Utrecht (the Netherlands) and London, (UK) – Lumeon, the leader in Care Pathway Management (CPM), to... |
| 21.11.2019 | Axonics® raises $110 million via Public Offering of Common S... | Irvine, CA (US) – Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), a medical techno... |
| 14.11.2019 | Axonics® announces U.S. FDA approval for its sacral neuromod... | Irvine, CA (US) – Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company... |
| 30.10.2019 | Sanifit announces positive Phase 2b data in cardiovascular c... | Utrecht (The Netherlands), Palma (Spain) and San Diego (US) – Sanifit, a clinical-stage biopharmaceu... |
| 28.10.2019 | Nyxoah publishes positive clinical data | Utrecht (The Netherlands) and Mont-Saint-Guibert (Belgium) – Nyxoah S.A., a healthtech company focus... |
| 03.10.2019 | Axonics® Provides Full One-Year Results from ARTISAN-SNM Piv... | Durable Outcomes Highlighted in Plenary Session Presentation; Expanding on Positive Topline Data Rel... |
| 26.09.2019 | Acacia Pharma announces new BARHEMSYS® PDUFA date of 26 febr... | Utrecht (The Netherlands) and Cambridge (Massachusetts) – Gilde Healthcare company Acacia Pharma (BR... |
| 09.09.2019 | Axonics receives FDA approval for neurostimulator to treat f... | Utrecht (The Netherlands), Cambridge (United States) – Gilde Healthcare company Axonics, a medical t... |
| 03.09.2019 | Ablative Solutions Announces Positive 12-Month Results from ... | SAN JOSE, Calif. and PARIS – Ablative Solutions, Inc., a company pioneering new approaches for the t... |
| 19.08.2019 | CVRx obtains FDA approval for heart failure neuromodulation ... | Utrecht (The Netherlands), Cambridge (United States) – Gilde Healthcare company CVRx, Inc., announce... |
| 25.07.2019 | Gilde Healthcare announces acquisition of Breath Therapeutic... | Utrecht (The Netherlands), Cambridge (United States) – Gilde Healthcare today announced it has sold ... |
| 16.07.2019 | AM-Pharma Raises Record Financing of €116m [$133m] for Phase... | Bunnik, The Netherlands – AM-Pharma B.V. (‘AM-Pharma, the Company’), a clinical stage biopharmaceuti... |
| 11.07.2019 | Ablative Solutions Announces Appointment of Kate Rumrill as ... | San Jose, Calif., US - Ablative Solutions, Inc., a company pioneering new approaches to the treatmen... |
| 08.07.2019 | Acacia Pharma plans to resubmit the BARHEMSYS® NDA in Q3 201... | Cambridge, UK and Indianapolis, US - Acacia Pharma, a pharmaceutical company developing and commerci... |
| 02.07.2019 | Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical O... | IRVINE, Calif., /PRNewswire/ -- Inari Medical, Inc. announced today that the company has appointed T... |
| 26.06.2019 | Sanifit announces €72.2M ($80.9M) financing in Spain’s large... | Palma, Spain and San Diego, USA – Sanifit, a clinical-stage biopharmaceutical company focused on tre... |
| 04.06.2019 | Gilde Healthcare co-leads $37M financing of Vesper Medical t... | Utrecht (The Netherlands), Cambridge (United States) - Gilde Healthcare today announces its investme... |
| 20.05.2019 | QIAstat-Dx gains 510(k) clearance by FDA, triggering milesto... | Utrecht, The Netherlands - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced 5... |
| 26.03.2019 | Breath Therapeutics Announces Initiation of Global Phase 3 T... | Munich, Germany and Menlo Park, Calif. — Breath Therapeutics, a private company developing advanced ... |
| 19.03.2019 | Nyxoah receives European CE Mark approval for the Genio™ sys... | Utrecht, The Netherlands and Mont-Saint-Guibert, Belgium – Nyxoah S.A., a healthtech company focusin... |
| 11.03.2019 | Gilde Healthcare acquires healthcare food supplier Eetgemak ... | Utrecht and Frankfurt - Gilde Healthcare, the European specialist investor in healthcare, acquires a... |
| 07.03.2019 | Gilde Healthcare raises €200 million for new private equity ... | Utrecht (the Netherlands) and Frankfurt (Germany) – Gilde Healthcare, the European specialist invest... |
| 05.03.2019 | Axonics® Announces Fourth Quarter and Full Year 2018 Financi... | IRVINE, CA – Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focus... |
| 21.02.2019 | Gilde Healthcare leads EUR 20M Series A financing round of C... | Utrecht, The Netherlands and Boston, US - Calypso Biotech (Amsterdam, The Netherlands), an emerging ... |
| 14.02.2019 | Axonics® Submits Full Body MRI Data to U.S. Food & Drug ... | Irvine, CA – Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focus... |
| 22.01.2019 | Acacia Pharma reports positive cardiac safety data for BARHE... | Cambridge, UK and Indianapolis, US - Acacia Pharma (EURONEXT: ACPH) announces results from its lates... |
| 03.01.2019 | Gilde Healthcare leads USD 77 million financing round of hyp... | Utrecht (The Netherlands), Boston (United States) – Ablative Solutions, Inc. (Kalamazoo, Michigan), ... |
| 12.12.2018 | Acacia Pharma announces positive clinical results for APD403... | Cambridge, UK and Indianapolis, US - Acacia Pharma Group plc ("Acacia Pharma", the "C... |